Patient Data, Disease Characteristics, and Treatment and Imaging Parameters
| Variable | Value |
| Patients (n) | 21 |
| Mean age (y) | 56.8 (range, 35–79) |
| Tumors treated (n) | 25 |
| Type of primary cancer (n) | |
| Colorectal | 23 |
| Sarcoma | 1 |
| Breast | 1 |
| Ablative modality (n) | |
| Radiofrequency ablation | 16 |
| Microwave ablation | 9 |
| Mean tumor size (cm) | 2.3 (range, 0.7–4.6) |
| Mean preablation 18F-FDG dose (MBq) | 159.1 (range, 144.3–177.6) |
| Mean postablation 18F-FDG dose (MBq) | 307.1 (range, 162.8–325.6) |
| Mean plasma glucose at administration of first 18F-FDG dose (mg/dL) | 114.5 (range, 75–209) |
| Mean time between administration of first dose and PET/CT acquisition (min) | 92 |
| Mean time between administration of second dose and PET/CT acquisition (min) | 53 |